These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38093618)

  • 21. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy.
    Cai HJ; Fang JH; Kong FL; Xu CK; Chen CH; Wang W; Huang B
    Acta Radiol; 2022 Apr; 63(4):553-558. PubMed ID: 33779301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of GreenLight XPS Laser Vapoenucleation in Prostates Measuring Over 150 mL.
    Stone BV; Chughtai B; Forde JC; Tam AW; Lewicki P; Te AE
    J Endourol; 2016 Aug; 30(8):906-12. PubMed ID: 27203515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser.
    Cindolo L; Ruggera L; Destefanis P; Dadone C; Ferrari G
    Int Urol Nephrol; 2017 Mar; 49(3):405-411. PubMed ID: 28044238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three years outcomes of transperineal laser ablation of the prostate.
    Minafra P; DE Rienzo G; Gerbasi S; Cindolo L; Battaglia M; Ditonno P
    Minerva Urol Nephrol; 2023 Aug; 75(4):471-478. PubMed ID: 37314812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction.
    Destefanis P; Sibona M; Vitiello F; Vercelli E; Micai L; Montefusco G; Mangione C; Bracco F; Colucci F; De Nunzio C; Gontero P
    Prostate Cancer Prostatic Dis; 2023 Oct; ():. PubMed ID: 37853099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified holmium laser enucleation for benign prostatic obstruction to preserve sexual and ejaculatory function.
    Long Depaquit T; Baboudjian M; Chiron P; Corral R; Anastay V; Bastide C; Toledano H
    Fr J Urol; 2024 Mar; 34(2):102581. PubMed ID: 38717462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study.
    Viitala A; Anttinen M; Wright C; Virtanen I; Mäkelä P; Hovinen T; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
    BJU Int; 2022 Feb; 129(2):208-216. PubMed ID: 34161649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data.
    Cho MC; Yoo S; Park J; Cho SY; Son H; Oh SJ; Paick JS
    BJU Int; 2019 May; 123(5A):E34-E42. PubMed ID: 30582661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study.
    Canat HL; Gurbuz C; Bozkurt M
    Int Urol Nephrol; 2023 Nov; 55(11):2747-2752. PubMed ID: 37498422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
    Gilling P; Reuther R; Kahokehr A; Fraundorfer M
    BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience.
    Laganà A; Di Lascio G; Di Blasi A; Licari LC; Tufano A; Flammia RS; De Carolis A
    World J Urol; 2023 Apr; 41(4):1157-1162. PubMed ID: 36853444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.
    Pacella CM; Patelli G; Iapicca G; Manenti G; Perretta T; Ryan CP; Esposito R; Mauri G
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):356-363. PubMed ID: 31827239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.
    Patelli G; Ranieri A; Paganelli A; Mauri G; Pacella CM
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1440-1446. PubMed ID: 28474112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of 180-W GreenLight laser photoselective vaporization of the prostate for storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors.
    Hsieh YC; Wang CT; Kao YL; Cheng YS; Wu KY; Ho YH; Chuang MS; Huang YC; Ou YC
    Neurourol Urodyn; 2024 Mar; 43(3):646-654. PubMed ID: 38314960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP Experience.
    Gild P; Vetterlein MW; Daoud I; Ludwig TA; Soave A; Marks P; Chun FK; Ahyai S; Dahlem R; Fisch M; Rink M; Meyer CP; Becker A
    J Endourol; 2023 Mar; 37(3):316-322. PubMed ID: 36352826
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-guided transrectal prostate laser ablation for benign prostatic hypertrophy: a retrospective cohort study.
    Harman A; Toth R; Mobley Z; Sartin D; Karamanian A
    Radiol Med; 2024 Sep; 129(9):1412-1423. PubMed ID: 39154318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.